mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.5 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.5 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.5 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.5 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.5 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.6 |